The aberrant asynchronous replication - characterizing lymphocytes of cancer patients - is erased following stem cell transplantation

BMC Cancer

Volumn 10, Issue , 2010, Pages

  Nagler, Arnon ^a   Cytron, Samuel ^b   Mashevich, Maya ^c   Korenstein Ilan, Avital ^c   Avivi, Lydia ^c  

^a SHEBA MEDICAL CENTER   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AZACITIDINE; PHYTOHEMAGGLUTININ; PROTEIN P53; TRANSCRIPTION FACTOR RUNX1; DNA METHYLTRANSFERASE; ENZYME INHIBITOR; RUNX1 PROTEIN, HUMAN; TP53 PROTEIN, HUMAN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ALLELE; ALLOGENEIC STEM CELL TRANSPLANTATION; ANEUPLOIDY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER PATIENT; CHROMOSOME 17; CHROMOSOME 21; CHROMOSOME ABERRATION; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOGENETICS; EPIGENETICS; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DOSAGE; GENE LOCUS; GENE REPLICATION; GENETIC MARKER; HEMATOLOGIC MALIGNANCY; HUMAN; IN VITRO STUDY; LYMPHOCYTE; MICROSATELLITE MARKER; MULTIPLE MYELOMA; ADOLESCENT; ADULT; AGED; ALLOTRANSPLANTATION; BLOOD DISEASE; CELL CULTURE; CHILD; COMPARATIVE STUDY; DNA REPLICATION TIMING; DRUG ANTAGONISM; DRUG EFFECT; FEMALE; GENETIC EPIGENESIS; GENETICS; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PRESCHOOL CHILD; STEM CELL TRANSPLANTATION; TIME; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANEUPLOIDY; AZACITIDINE; CELLS, CULTURED; CHILD; CHILD, PRESCHOOL; CHROMOSOMES, HUMAN, PAIR 17; CHROMOSOMES, HUMAN, PAIR 21; CORE BINDING FACTOR ALPHA 2 SUBUNIT; DNA MODIFICATION METHYLASES; DNA REPLICATION TIMING; ENZYME INHIBITORS; EPIGENESIS, GENETIC; FEMALE; HEMATOLOGIC NEOPLASMS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LYMPHOCYTES; MALE; MIDDLE AGED; STEM CELL TRANSPLANTATION; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; TUMOR SUPPRESSOR PROTEIN P53; YOUNG ADULT;

EID: 77952513084     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-10-230     Document Type: Article

References (38)

1. Ohlsson R. Widespread monoallelic expression. Science 2007, 318:1077-1078. 10.1126/science.1150705, 18006729.
2. Yang PK, Kuroda M. Noncoding RNAs and intranuclear positioning of monoallelic gene expression. Cell 2007, 128:777-786. 10.1016/j.cell.2007.01.032, 17320513.
3. Goldmit M, Bergman Y. Monoallelic gene expression: a repertoire of recurrent themes. Immunol Rev 2004, 200:197-214. 10.1111/j.0105-2896.2004.00158.x, 15242406.
4. Knoll JHM, Cheng SD, Lalande M. Allele specificity of DNA replication timing in the Angelmann/Prader-Willi syndrome imprinted chromosomal region. Nat Genet 1994, 6:41-46. 10.1038/ng0194-41, 8136833.
5. Gunaratne PH, Nakao M, Ledbetter DH, Sutcliffe JS, Chinault AC. Tissue-specific and allele-specific replication timing control in the imprinted human Prader-Willi syndrome region. Genes Dev 1995, 9:808-820. 10.1101/gad.9.7.808, 7705658.
6. White LM, Rogan PK, Nicholls RD, Wu BL, Korf B, Knoll JHM. Allele specific replication of 15q11-q13 loci: a diagnostic test for uniparental disomy. Am J Hum Genet 1996, 59:423-430. 1914739, 8755930.
7. Dotan ZA, Dotan A, Litmanovitch T, Ravia Y, Oniasvili N, Leibovitch I, Ramon J, Avivi L. Modification in the inherent mode of allelic replication in lymphocytes of patients suffering from renal cell carcinoma: a novel genetic alteration associated with malignancy. Genes Chromosomes Cancer 2000, 27:270-277. 10.1002/(SICI)1098-2264(200003)27:3<270::AID-GCC7>3.0.CO;2-7, 10679916.
8. Dotan ZA, Dotan A, Ramon J, Avivi L. Altered mode of allelic replication accompanied by aneuploidy in peripheral blood lymphocytes of prostate cancer patients. Int J Cancer 2004, 111:60-66. 10.1002/ijc.20237, 15185343.
9. Torchia BS, Call LM, Migeon BR. DNA replication analysis of FMR1, XIST, and factor 8C loci by FISH shows nontranscribed X-linked genes replicate late. Am J Hum Genet 1994, 55:96-104. 1918226, 8023856.
10. Boggs BA, Chinault AC. Analysis of the replication timing properties of human X-chromosomal loci by fluorescence in-situ hybridization. Pro Natl Acad Sci USA 1994, 91:6083-6087.
11. Mostoslavsky R, Singh N, Tenzen T, Goldmit M, Gabay C, Elizur S, Qi P, Reubinoff BE, Chess A, Cedar H, Bergman Y. Asynchronous replication and allelic exclusion in the immune system. Nature 2001, 414:221-225. 10.1038/35102606, 11700561.
12. Ensminger AW, Chess A. Coordinated replication timing of monoallelically expressed genes along human autosomes. Hum Mol Genet 2004, 13:651-658. 10.1093/hmg/ddh062, 14734625.
13. Gimelbrant AA, Ensminger AW, Qi P, Zucker J, Chess A. Monoallelic expression and asynchronous replication of p120 catenin in mouse and human cells. J of Biol Chem 2005, 280:1354-1359.
14. Boggs BA, Chinault AC. Analysis of DNA replication by fluorescence in situ hybridization. Methods, A Companion to Methods Enzymol 1997, 13:259-270.
15. Amiel A, Litmanovitch T, Lishner M, Mor A, Gaber E, Tangi I, Fejgin MD, Avivi L. Temporal differences in replication timing of homologous loci in malignant cells derived from CML and lymphoma patients. Genes Chromosomes Cancer 1998, 22:225-231. 10.1002/(SICI)1098-2264(199807)22:3<225::AID-GCC8>3.0.CO;2-Y, 9624534.
16. Korenstein-Ilan A, Amiel A, Lalezari S, Lishner M, Avivi L. Allele specific replication associated with aneuploidy in blood cells of patients with hematologic malignancies. Cancer Genet Cytogenet 2002, 139:97-103. 10.1016/S0165-4608(02)00610-6, 12550768.
17. Dotan ZA, Dotan A, Ramon J, Avivi L. Aberrant allele-specific replication, independent of parental origin, in blood cells of cancer patients. BMC Cancer 2008, 8:390. doi:10.1186/1471-2407-8-390, 10.1186/1471-2407-8-390, 2629776, 19109880.
18. Litmanovitch T, Altaras MM, Dotan A, Avivi L. Asynchronous replication of homologous a-satellite DNA loci in man is associated with non-disjunction. Cytogenet Cell Genet 1998, 81:26-35. 10.1159/000015003, 9691171.
19. Haaf T. The effects of 5-azacytidine and 5-azadeoxycytidine on chromosome structure and function: implications for methylation-associated cellular processes. Pharmacol Ther 1995, 65:19-46. 10.1016/0163-7258(94)00053-6, 7536332.
20. Garcia-Manero G. Demethylating agents in myeloid malignancies. Curr Opin Oncol 2008, 20:705-710. 10.1097/CCO.0b013e328313699c, 18841054.
21. Nagler A, Korenstein-Ilan A, Amiel A, Avivi L. Granulocyte colony-stimulating factor generates epigenetic and genetic alterations in lymphocytes of normal volunteer donors of stem cells. Exp Hematol 2004, 32:122-130. 10.1016/j.exphem.2003.09.007, 14725909.
22. Petitjean A, Achatz MI, Borresen-Dale AL, Hainaut P, Olivier M. TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes. Oncogene 2007, 26:2157-2165. 10.1038/sj.onc.1210302, 17401424.
23. Zhang Y, Rowley JD. Chromatin structural elements and chromosomal translocations in leukemia. DNA Repair 2006, 5:1282-1297. 10.1016/j.dnarep.2006.05.020, 16893685.
24. Shimoni A, Nagler A. Clinical implications of minimal residual disease monitoring for stem cell transplantation after reduced intensity and nonmyeloablative conditioning. Acta Haematol 2004, 112:93-104. 10.1159/000077564, 15179009.
25. Lengauer C, Kinzler KW, Vogelstein B. Genetic instabilities in human cancers. Nature 1998, 396:643-649. 10.1038/25292, 9872311.
26. Pulsipher M. Is G-CSF-mobilized peripheral stem cell harvest harmful?. Pediatr Blood Cancer 2006, 46:595-596.
27. Pulsipher MA, Nagler A, Iannone R, Nelson RM. Weighing the risks of G-CSF administration, leukopheresis, and standard marrow harvest: ethical and safety considerations for normal pediatric hematopoietic cell donors. Pediatr Blood Cancer 2006, 46:422-433. 10.1002/pbc.20708, 16411207.
28. Amariglio N, Jacob-Hirsch J, Shimoni A, Leiba M, Rechavi G, Nagler A. Changes in gene expression pattern following granulocyte colony-stimulating factor administration to normal stem cell sibling donors. Acta Haematol 2007, 117:68-73. 10.1159/000096856, 17106189.
29. Herman JG, Baylin SB. Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 2003, 349:2042-2054. 10.1056/NEJMra023075, 14627790.
30. Ting AH, McGarvey KM, Baylin SB. The cancer epigenome--components and functional correlates. Genes Dev 2006, 20:3215-3231. 10.1101/gad.1464906, 17158741.
31. Jones PA, Baylin SB. The epigenomic of cancer. Cell 2007, 128:683-692. 10.1016/j.cell.2007.01.029, 17320506.
32. Nishihara S, Hayashida T, Mitsuya K, Schultz TC, Ikeguchi M, Kaibara N, Oshimura M. Multipoint imprinting analysis in sporadic colorectal cancers with and without microsatellite instability. Int J Oncol 2000, 17:317-322.
33. Nakagawa H, Chadwick RB, Peltomaki P, Plass C, Nakamura Y, de la Chapelle A. Loss of imprinting of the insulin-like growth factor II gene occurs by biallelic methylation in a core region of H19-associated CTCF-binding sites in colorectal cancer. Pro Natl Acad Sci USA 2001, 98:591-596.
34. Cui H, Cruz-Correa M, Giardiello FM, Hutcheon DF, Kafonek DR, Brandenburg S, Wu Y, He X, Powe NR, Feinberg AP. Loss of IGF2 imprinting: a potential Marker of colorectal cancer risk. Science 2003, 299:1753-1775. 10.1126/science.1080902, 12637750.
35. Clement G, Bosman FD, Fontolliet C, Behattar J. Monoallelic methylation of the APC promoter is altered in normal gastric mucossa associated with neoplastic lesions. Cancer Res 2004, 64:6867-6873. 10.1158/0008-5472.CAN-03-2503, 15466175.
36. Frigola J, Song J, Stirzaker C, Hinshelwood RA, Peinado MA, Clark SJ. Epigenetic remodeling in colorectal cancer results in coordinate gene suppression across an entire chromosome band. Nat Genet 2006, 38:540-549. 10.1038/ng1781, 16642018.
37. Egger G, Liang G, Jones Aparicio PA. Epigenetics in human diseases and prospects for epigenetic therapy. Nature 2004, 429:457-463. 10.1038/nature02625, 15164071.
38. Constantinides PG, Jones PA, Gevers W. Functional striated muscle cells fromnon-myoblast precursors following 5-azacytidine treatment. Nature 1977, 267:364-366. 10.1038/267364a0, 68440.